Ventolin (Albuterol) Dosing for Acute Bronchospasm
For acute bronchospasm in adults, administer 2.5 mg albuterol in 3 mL saline via nebulizer every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed; for children 5-11 years use 1.25-5 mg every 20 minutes for 3 doses, then 0.15-0.3 mg/kg (up to 10 mg) every 1-4 hours; and for children under 5 years use 0.63 mg/3 mL. 1
Age-Specific Dosing Protocols
Adults
- Initial treatment: 2.5 mg in 3 mL saline via nebulizer every 20 minutes for 3 doses 1
- Maintenance: 2.5-10 mg every 1-4 hours as needed 1
- Severe exacerbations: Consider continuous nebulization at 7.5 mg/hour 1, 2
- MDI alternative: 2 puffs (200 mcg/puff) every 4-6 hours 3
Children 5-11 Years
- Initial treatment: 1.25-5 mg in 3 mL saline every 20 minutes for 3 doses 1
- Maintenance: 0.15-0.3 mg/kg (maximum 10 mg) every 1-4 hours 1
- MDI alternative: 2 puffs every 4-6 hours 3
Children Under 5 Years
- Recommended dose: 0.63 mg/3 mL via nebulizer 1
- MDI alternative: 1-2 puffs every 4-6 hours via face mask with proper seal 3
Administration Considerations
Nebulizer Technique
- Dilute aerosols to a minimum of 3 mL at a gas flow of 6-8 L/min for optimal delivery 1
- Use jet nebulizers only; ultrasonic nebulizers are ineffective for suspensions 3
- For children under 4 years, use a face mask that fits snugly over nose and mouth 3
Severe Exacerbations
- Continuous nebulization: 7.5 mg/hour is the recommended dose for acute severe exacerbations 1, 2
- Higher doses (15 mg/hour) offer no additional benefit in peak flow improvement or length of stay compared to 7.5 mg/hour 2
- May combine with ipratropium bromide 0.25-0.5 mg for severe cases 3, 1
Clinical Monitoring and Safety
Expected Response
- Onset of action: Improvement in pulmonary function typically occurs within 5 minutes 4
- Peak effect: Maximum improvement usually occurs at approximately 1 hour and remains close to peak for 2 hours 4
- Duration: Clinically significant improvement (≥15% increase in FEV1) continues for 3-4 hours in most patients, up to 6 hours in some 4
Common Side Effects
- Tachycardia, skeletal muscle tremor, hypokalemia, headache, and hyperglycemia 3, 1
- These effects are generally minimal with inhaled route compared to systemic administration 3
Warning Signs of Poor Control
- Increasing use or lack of expected effect indicates diminished asthma control 3, 1
- Regular use exceeding 2 days per week for symptom control (not prevention of exercise-induced bronchospasm) suggests need for controller medication adjustment 3, 1
Important Clinical Pitfalls
Preservative-Related Bronchospasm
- Multi-dose albuterol solutions containing benzalkonium chloride (BAC) can cause paradoxical bronchospasm with repeated nebulization 5
- BAC effects are cumulative and prolonged, particularly in patients with severe asthma receiving frequent treatments 5
- If a patient fails to improve despite appropriate dosing, consider switching to preservative-free formulations 5